Quantitative Sensory Testing in Chronic Pain Patients Undergoing Opioid Treatment and Opioid Tapering
CompletedNot applicableNCT03375216
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Few studies have used quantitative sensory tests to study the effect of chronic opioid treatment on sensation. The investigators will test chronic pain patients who are on different MEDDs, normal volunteers, and patients undergoing an opioid taper. This will be the first study to perform sensory testing on patients while undergoing an opioid taper on an outpatient basis.
Study details
- Official title
- Quantitative Sensory Testing in Chronic Pain Patients Undergoing Opioid Treatment and Opioid Tapering
- Conditions
- Analgesic Drug Dependence
- Sensory Deficit
- Interventions
- Behavioral: sensory testing (Heat, cold, and pressure)
- Behavioral: Promis Survey
- Sponsor
- The University of Texas Medical Branch, Galveston
- Start date
- 2017-12-22
- Primary completion
- 2023-11-18
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patient age between 18 and 75 * History of chronic pain for at least 3 months * Patients may have been selected for opioid taper by their pain physicians. * Patients may or may not be on opioid therapy. * They must have the ability to understand the protocol and provide voluntary, written, informed consent. Exclusion Criteria: * Cancer pain * Unstable medical conditions (including but not limited to history of myocardial infarction within the past year, autoimmune diseases, uncontrolled diabetes with hemoglobin A1C of greater than 10) * Pregnancy * Inability to adequately answer surveys * History of substance abuse within 5 years * Surgery within the past month * Surgery planned during the next six months * Use of systemic steroids.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03375216